Reference
Menon S, et al. Indolent and fluctuating course of alemtuzumab induced grave's disease. Hormone Research in Paediatrics 94 (Suppl. 2): 123 (plus poster) abstr. 201, Sep 2021 [abstract]
Rights and permissions
About this article
Cite this article
Alemtuzumab/levothyroxine-sodium. Reactions Weekly 1896, 29 (2022). https://doi.org/10.1007/s40278-022-10820-8
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40278-022-10820-8